Pharma Prescribed with Poorya Amini, CEO of Risklick; AI in Pharma: A game-changer in Protocol Design

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Today, I’m joined by Poorya Amini, founder and CEO of Risklick, a Swiss digital health company that’s redefining how clinical trial protocols are designed. Poorya’s journey spans veterinary medicine, a PhD in pharmacology, and hands‑on experience managing cardiology trials at the University of Bern. In 2019, he launched Risklick to tackle one of pharma’s biggest bottlenecks: protocol inefficiency. Risklick’s flagship product, Protocol AI™, draws on a database of over 800,000 clinical trials to cut protocol development time by 50%, reduce amendments by 20%, and shorten implementation by 40%.